April 26, 2024 — Amae Health, a trailblazer in delivering patient-centered care for people with severe mental illness, announced the successful closing of its oversubscribed $15 million Series A funding round. Amae Health will use the capital to fuel its mission to revolutionize care for severe mental illness (SMI) through its innovative, psychiatry-led model.

April 1, 2024 — Peer-reviewed clinical pilot trial from Stanford University reports dramatic improvements in psychiatric and metabolic outcomes in bipolar disorder and schizophrenia patients.